allylamine has been researched along with Insulin Resistance in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jialal, I; Sheely, D | 1 |
| Bloks, VW; Groen, AK; Kuipers, F | 1 |
| Holst, JJ; Salen, G; Saumoy, M; Shang, Q; Xu, G | 1 |
| Abby, SL; Jones, MR; Lai, YL; Misir, S; Nagendran, S; Schwartz, SL; Xu, J | 1 |
| Bailey, CJ; Barnett, AH; Del Prato, S; Tahrani, AA | 1 |
| Dunn, FL; Grundy, SM; Vega, GL | 1 |
| Aroda, VR; Chou, HS; Garvey, WT; Henry, RR; Jones, MR; Mudaliar, S | 1 |
| Kahn, SE; Marcovina, SM; Marina, AL; Montgomery, BK; Utzschneider, KM; Wright, LA | 1 |
| Elisaf, MS; Florentin, M; Kei, AA; Kostapanos, MS; Liamis, G; Liberopoulos, EN; Rizos, CV | 1 |
| Cobelli, C; Dalla Man, C; Law, JH; Piccinini, F; Rizza, RA; Sathananthan, M; Smushkin, G; Vella, A; Zinsmeister, AR | 1 |
2 review(s) available for allylamine and Insulin Resistance
| Article | Year |
|---|---|
Beyond intestinal soap--bile acids in metabolic control.
Topics: Allylamine; Animals; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Energy Metabolism; Fibroblast Growth Factors; Glycated Hemoglobin; Humans; Insulin Resistance; Lipid Metabolism; Male; Mice; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction | 2014 |
Management of type 2 diabetes: new and future developments in treatment.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Allylamine; Anticholesteremic Agents; Bariatric Surgery; Bile Acids and Salts; Cardiovascular System; Colesevelam Hydrochloride; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glucokinase; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Resistance; Insulin-Secreting Cells; Liver; Obesity; Peptides; Randomized Controlled Trials as Topic; Receptors, Dopamine D2; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Venoms | 2011 |
6 trial(s) available for allylamine and Insulin Resistance
| Article | Year |
|---|---|
The effect of colesevelam hydrochloride on insulin sensitivity and secretion in patients with type 2 diabetes: a pilot study.
Topics: Adult; Aged; Algorithms; Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Pilot Projects; Placebos; Postprandial Period | 2010 |
Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.
Topics: Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Colesevelam Hydrochloride; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome | 2011 |
Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Middle Aged; Sulfonylurea Compounds; United States; Young Adult | 2012 |
Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and β-cell function.
Topics: Adult; Aged; Allylamine; Blood Glucose; Colesevelam Hydrochloride; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged | 2012 |
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Blood Glucose; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.
Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; C-Peptide; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Postprandial Period | 2013 |
2 other study(ies) available for allylamine and Insulin Resistance
| Article | Year |
|---|---|
Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.
Topics: Allylamine; Animals; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Body Weight; Carrier Proteins; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Colesevelam Hydrochloride; Cyclic N-Oxides; Dietary Carbohydrates; Dietary Fats; Gene Expression; Glucagon-Like Peptide 1; Glucose Tolerance Test; Ileum; Insulin; Insulin Resistance; Liver; Male; Membrane Glycoproteins; Obesity; Organic Anion Transporters, Sodium-Dependent; Portal Vein; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Symporters; Triglycerides; Tropanes | 2010 |